Variant report

Variant	nsv978413
Chromosome Location	chr17:33679552-33681509
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:19)
CpG islands
(count:61)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:19 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr17:33679520-33679670	WI-38	lung:	n/a	n/a
2	POLR2A	chr17:33679262-33679796	SK-N-MC	brain:	n/a	n/a
3	POLR2A	chr17:33680253-33681052	GM12892	blood:	n/a	n/a
4	POLR2A	chr17:33680294-33681045	GM12892	blood:	n/a	n/a
5	POLR2A	chr17:33680590-33680873	A549	lung:	n/a	n/a
6	POLR2A	chr17:33680149-33681010	GM12892	blood:	n/a	n/a
7	POLR2A	chr17:33681504-33681555	Hela-S3	cervix:	n/a	n/a
8	POLR2A	chr17:33680594-33680756	H1-hESC	embryonic stem cell:	n/a	n/a
9	POLR2A	chr17:33680574-33680842	GM12878	blood:	n/a	n/a
10	POLR2A	chr17:33680667-33680832	MCF-7	breast:	n/a	n/a
11	POLR2A	chr17:33680384-33680520	Gliobla	brain:	n/a	n/a
12	POLR2A	chr17:33680878-33680879	A549	lung:	n/a	n/a
13	POLR2A	chr17:33680280-33680909	GM12878	blood:	n/a	n/a
14	POLR2A	chr17:33680567-33680802	GM12878	blood:	n/a	n/a
15	POLR2A	chr17:33680386-33680892	GM12892	blood:	n/a	n/a
16	POLR2A	chr17:33680640-33680923	Gliobla	brain:	n/a	n/a
17	POLR2A	chr17:33680686-33680812	GM12878	blood:	n/a	n/a
18	POLR2A	chr17:33680765-33680898	Hela-S3	cervix:	n/a	n/a
19	POLR2A	chr17:33680802-33680834	H1-hESC	embryonic stem cell:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:33679797-33679847	HUVEC	blood vessel:	n/a
2	chr17:33679797-33679847	NH-A	brain:	n/a
3	chr17:33679797-33679847	HCF	heart:	n/a
4	chr17:33679797-33679847	AoSMC	blood vessel:	n/a
5	chr17:33679797-33679847	HepG2	liver:	n/a
6	chr17:33679797-33679847	NB4	blood:	n/a
7	chr17:33679797-33679847	CMK	blood:	n/a
8	chr17:33679797-33679847	HEEpiC	esophagus:	n/a
9	chr17:33679797-33679847	GM06990	blood:	n/a
10	chr17:33679797-33679847	NHBE	bronchial:	n/a
11	chr17:33679797-33679847	PFSK-1	brain:	n/a
12	chr17:33679797-33679847	ovcar-3	ovarian:	n/a
13	chr17:33679797-33679847	ProgFib	skin:	n/a
14	chr17:33679797-33679847	RPTEC	kidney:	n/a
15	chr17:33679797-33679847	Hepatocyte	liver:	n/a
16	chr17:33679797-33679847	BE2_C	brain:	n/a
17	chr17:33679797-33679847	NHDF-neo	bronchial:	n/a
18	chr17:33679797-33679847	NT2-D1	testis:	n/a
19	chr17:33679797-33679847	PANC-1	pancreas:	n/a
20	chr17:33679797-33679847	HRPEpiC	eye:	n/a
21	chr17:33679797-33679847	HCPEpiC	choroid plexus:	n/a
22	chr17:33679797-33679847	GM12891	blood:	n/a
23	chr17:33679797-33679847	HMEC	breast:	n/a
24	chr17:33679797-33679847	Hela-S3	cervix:	n/a
25	chr17:33679797-33679847	HNPCEpiC	eye:	n/a
26	chr17:33679797-33679847	AG04449	skin:	fetal
27	chr17:33679797-33679847	ECC-1	luminal epithelium:	n/a
28	chr17:33679797-33679847	SAEC	small airway:	n/a
29	chr17:33679797-33679847	SK-N-SH_RA	brain:	n/a
30	chr17:33679797-33679847	HCM	heart:	n/a
31	chr17:33679797-33679847	AG09319	gingival:	n/a
32	chr17:33679797-33679847	H1-hESC	embryonic stem cell:	embryo
33	chr17:33679797-33679847	Jurkat	blood:	n/a
34	chr17:33679797-33679847	HL-60	blood:	n/a
35	chr17:33679797-33679847	SK-N-SH	brain:	n/a
36	chr17:33679797-33679847	HEK293	kidney:	embryo
37	chr17:33679797-33679847	HAEpiC	amniotic membrane:	n/a
38	chr17:33679797-33679847	HPAEpiC	pulmonary alveolar:	n/a
39	chr17:33679797-33679847	LNCaP	prostate:	n/a
40	chr17:33679797-33679847	K562	blood:	n/a
41	chr17:33679797-33679847	HRCEpiC	kidney:	n/a
42	chr17:33679797-33679847	T-47D	breast:	n/a
43	chr17:33679797-33679847	A549	lung:	n/a
44	chr17:33679797-33679847	MCF10A-Er-Src	breast:	n/a
45	chr17:33679797-33679847	SK-N-MC	brain:	n/a
46	chr17:33679797-33679847	HRE	kidney:	n/a
47	chr17:33679797-33679847	AG04450	lung:	fetal
48	chr17:33679797-33679847	AG09309	skin:	n/a
49	chr17:33679797-33679847	U87	brain:	n/a
50	chr17:33679797-33679847	SKMC	muscle:	n/a

No data

Variant related genes	Relation type
SLFN11	TF binding region
SLFN11	CpG island

Extended variants
information (count: 125 )
Associated
traits (count: 112 )

Variant overlapped rSNPs/rCNVs (count:125 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs376285868	chr17:33679559-33679560	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs267604807	chr17:33679603-33679604	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs545102309	chr17:33679609-33679610	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs3803860	chr17:33679616-33679617	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs531042478	chr17:33679618-33679619	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs141712070	chr17:33679621-33679622	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs188760591	chr17:33679633-33679634	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs147085136	chr17:33679635-33679636	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs200608504	chr17:33679637-33679638	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs567083866	chr17:33679652-33679653	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs71366434	chr17:33679659-33679660	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs371750493	chr17:33679695-33679696	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs200148710	chr17:33679696-33679697	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs201730196	chr17:33679697-33679698	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs143462796	chr17:33679699-33679700	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs147143249	chr17:33679701-33679702	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs192840240	chr17:33679704-33679705	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs148600188	chr17:33679712-33679713	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs142470821	chr17:33679728-33679729	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs574471246	chr17:33679730-33679731	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs201143062	chr17:33679738-33679739	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs541914273	chr17:33679748-33679749	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs199944678	chr17:33679749-33679750	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs150899761	chr17:33679761-33679762	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs184079642	chr17:33679765-33679766	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs546044791	chr17:33679779-33679780	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs377363363	chr17:33679780-33679781	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs199939770	chr17:33679787-33679788	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs150521243	chr17:33679788-33679789	Enhancers Weak transcription Bivalent Enhancer Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs541299834	chr17:33679827-33679828	Enhancers Weak transcription Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs200734680	chr17:33679887-33679888	Enhancers Weak transcription Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs149052916	chr17:33679900-33679901	Enhancers Weak transcription Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs563404138	chr17:33679903-33679904	Enhancers Weak transcription Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs561409275	chr17:33679909-33679910	Enhancers Weak transcription Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs79638520	chr17:33679943-33679944	Enhancers Weak transcription Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs370460575	chr17:33680004-33680005	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs199890326	chr17:33680008-33680009	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs112261872	chr17:33680011-33680012	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs143096498	chr17:33680015-33680016	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs146588899	chr17:33680022-33680023	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs532707581	chr17:33680041-33680042	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs202123744	chr17:33680060-33680061	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs201406101	chr17:33680061-33680062	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs372849197	chr17:33680066-33680067	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs377115038	chr17:33680077-33680078	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs141302419	chr17:33680081-33680082	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs3744370	chr17:33680107-33680108	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs143643982	chr17:33680127-33680128	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs146793614	chr17:33680139-33680140	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs201150761	chr17:33680141-33680142	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:112)

Disease	PMID	Source
Melanoma	18172304	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	17603634	CNVD
T-cell lymphomas	19863542	CNVD
Cancer	16751803	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
Breast cancer	21858162	CNVD
Breast cancer	16397240	CNVD
Myxofibrosarcoma	16751306	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17157792	CNVD
Bladder cancer	19088036	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Meningioma	19431122	CNVD
Neurocytoma	17123091	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Lung cancer	21911935	CNVD
Breast cancer	22048815	CNVD
Cervical cancer	21062161	CNVD
Colorectal cancer	22860045	CNVD
Ductal carcinoma	18381933	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16417655	CNVD
Renal cysts	20603712	CNVD
Epilepsy	21858020	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Autism	20587423	CNVD
Renal cysts	20587423	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Mayer-Rokitansky-Kuster-Hauser syndrome	19889212	CNVD
Endometrial cancer	23636398	CNVD
Urothelial cell carcinoma	18451213	CNVD
Gastric cancer	24379144	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16785998	CNVD
Breast cancer	17850661	CNVD
Primary lung adenocarcinoma	16799635	CNVD
HIV/AIDS	18848619	CNVD
Rheumatoid arthritis	19220326	CNVD
Rheumatoid arthritis	18848619	CNVD
Systemic lupus erythematosus	19220326	CNVD
Systemic lupus erythematosus	18848619	CNVD
Type 1 diabetes	19220326	CNVD
HIV/AIDS	17330138	CNVD
Basal cell lymphoma	17053054	CNVD
Autism	19955444	CNVD
Schizophrenia	19955444	CNVD
Acute monocytic leukemia	16498392	CNVD
Breast cancer	20409316	CNVD
Myelodysplastic syndrome	18663149	CNVD
Breast cancer	17457667	CNVD
Breast cancer	16951389	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Lung cancer	19153074	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Breast cancer	20932292	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Lung cancer	18438408	CNVD
Recurrent pregnancy loss	19789632	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD

Chromatin state (count:103 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:33673800-33689800	Weak transcription	Gastric	stomach
2	chr17:33673800-33699800	Weak transcription	Ovary	ovary
3	chr17:33674000-33681600	Weak transcription	Duodenum Mucosa	Duodenum
4	chr17:33674000-33682600	Weak transcription	NHDF-Ad	bronchial
5	chr17:33674000-33686400	Weak transcription	Rectal Mucosa Donor 31	rectum
6	chr17:33674000-33695600	Weak transcription	Colonic Mucosa	Colon
7	chr17:33674000-33695600	Weak transcription	Placenta	Placenta
8	chr17:33674000-33698600	Weak transcription	Muscle Satellite Cultured Cells	--
9	chr17:33674200-33679600	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
10	chr17:33674200-33686000	Weak transcription	Brain Hippocampus Middle	brain
11	chr17:33674200-33699800	Weak transcription	Sigmoid Colon	Sigmoid Colon
12	chr17:33674400-33693600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
13	chr17:33674600-33694600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
14	chr17:33674800-33683600	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
15	chr17:33675000-33681400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
16	chr17:33675000-33686600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
17	chr17:33675000-33688400	Weak transcription	Colon Smooth Muscle	Colon
18	chr17:33675600-33684400	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr17:33675800-33687800	Strong transcription	Dnd41	blood
20	chr17:33675800-33694000	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr17:33675800-33699800	Weak transcription	Rectal Smooth Muscle	rectum
22	chr17:33676000-33687600	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
23	chr17:33676000-33689600	Weak transcription	Primary neutrophils fromperipheralblood	blood
24	chr17:33676000-33689600	Weak transcription	Stomach Smooth Muscle	stomach
25	chr17:33676400-33684800	Strong transcription	Primary hematopoietic stem cells short term culture	blood
26	chr17:33677600-33680000	Strong transcription	NHLF	lung
27	chr17:33677600-33680200	Strong transcription	Primary hematopoietic stem cells	blood
28	chr17:33677600-33680400	Strong transcription	Fetal Thymus	thymus
29	chr17:33677600-33681600	Weak transcription	Duodenum Smooth Muscle	Duodenum
30	chr17:33677600-33684800	Strong transcription	Monocytes-CD14+_RO01746	blood
31	chr17:33677600-33691400	Strong transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr17:33677600-33691400	Strong transcription	Primary monocytes fromperipheralblood	blood
33	chr17:33677800-33680000	Strong transcription	Primary B cells from cord blood	blood
34	chr17:33677800-33684200	Strong transcription	Primary Natural Killer cells fromperipheralblood	blood
35	chr17:33678000-33680000	Strong transcription	Thymus	Thymus
36	chr17:33678000-33680200	Strong transcription	Primary T helper cells PMA-I stimulated	--
37	chr17:33678000-33681400	Weak transcription	HUES48 Cell Line	embryonic stem cell
38	chr17:33678200-33680400	Strong transcription	IMR90 fetal lung fibroblasts Cell Line	lung
39	chr17:33678200-33680400	Weak transcription	Skeletal Muscle Male	skeletal muscle
40	chr17:33678200-33683000	Strong transcription	Primary mononuclear cells fromperipheralblood	Blood
41	chr17:33678200-33687800	Weak transcription	Skeletal Muscle Female	skeletal muscle
42	chr17:33678400-33681400	Weak transcription	Left Ventricle	heart
43	chr17:33678400-33700000	Weak transcription	Esophagus	oesophagus
44	chr17:33678600-33682800	Strong transcription	Primary T cells fromperipheralblood	blood
45	chr17:33678600-33687400	Strong transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
46	chr17:33678800-33684800	Strong transcription	Primary B cells from peripheral blood	blood
47	chr17:33679000-33680400	Strong transcription	Primary T regulatory cells fromperipheralblood	blood
48	chr17:33679000-33683000	Strong transcription	Spleen	Spleen
49	chr17:33679200-33680200	Strong transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr17:33679200-33680200	Strong transcription	Aorta	Aorta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links